Cosmetic Dermatology Old Bridge
Cosmetic Dermatology Old Bridge Cosmetic Dermatology Old Bridge Cosmetic Dermatology Old Bridge Cosmetic Dermatology Old Bridge

Featured Specials

Cosmetic Dermatology Old Bridge

Let Us Help you Ring
in the New Year

Click on the image above
for more information

Paybill
click on the image above
to pay your bill online.


Patient Education Dermatology Old Bridge

Welcome

Meet Our Newest Team Member

We are pleased to welcome, Dr. Anita M. Osmundson to our team of experts in the field of dermatologic surgery at Freehold Skin Clinic & Cancer Center.

Dr. Anita Osmundson's area of expertise is Mohs micrographic surgery, which is the specialized technique for the removal of skin cancers and the subsequent reconstructive surgical repairs.

Dr. Osmundson is a board certified dermatologist and a fellowship trained Mohs surgeon. She is a Fellow member of the American Academy of Dermatology, the American Society of Dermatologic Surgery and the American Society of Mohs Surgery. Dr. Osmundson competed both her intership and residency in dermatology at the Philadelphia College of Osteopathic Medicine where she also served as chief resident in dermatology. Dr. Osmundson then went on to complete a fellowship in Mohs Micrographic Surgery at Dermatology Associates of Tulsa under the direction of renowned Mohs Surgeon Dr. Edward Yob.

Dermatology Associates of Central NJ and Dr. Centurion have earned a reputation of high quality, personal patient care in the treatment and removal of skin cancers over many years. With Dr. Osmundson on board, we will continue to strive for excellence in the field of Dermatologic Surgery in our community.

Mohs Micrographic Surgery is highly specialized, allowing for the selective removal of the skin cancer with the preservation of as much of the surrounding normal tissue as is possible. Because of this complete systemic microscopic search for the “roots” of the skin cancer, Mohs Micrographic surgery offers the highest chance for complete removal of the cancer while sparing the normal tissue. The cure rate for new skin cancers undergoing Mohs surgery is 99%. As a result, Mohs Micrographic Surgery is very useful for large tumors, tumors with indistinct borders, tumors near vital functional or cosmetic structures, and tumors for which other forms of therapy have failed.


You have concerns about your appearance and have decided to seek the advice of a cosmetic dermatologist. At Dermatology Associates of Central New Jersey, we would like to assure you that your concerns are of great importance to us. From the time you enter our center, you are pleasantly greeted by highly trained professionals. They are motivated team players who are dedicated to their jobs and compassionate towards their patients. You will be treated with kindness by people you can trust.

If you are interested in learning more about any of our dermatology procedures, call 732-679-6300 or 732-780-7870 today to schedule an appointment.


Skin Cancer Fact Sheet

  • Substantially more than 1 million cases of skin cancer are diagnosed in the United States every year.
  • Basal cell and squamous cell carcinomas are the two most common forms of skin cancer, but are easily treated if detected early.
  • Current estimates are that one in five Americans will develop skin cancer in their lifetime.
  • The incidence of melanoma has been steadily increasing for the past 30 years. Since 1992, melanoma has increased 3.1 percent annually in non-Hispanic Caucasians, but in recent years it is increasing more rapidly in young white women (3.8 percent since 1995) and men age 65 and older (8.8 percent since 2003).
  • Melanoma is the most common form of cancer for young adults 25-29 years old and the second most common form of cancer for adolescents and young adults 15-29 years old.
  • Melanoma is increasing faster in females 15-29 years old than males in the same age group. In females 15-29 years old, the torso is the most common location for developing melanoma, which might be due to high-risk tanning behaviors.
  • Melanoma in individuals 10-39 years old is highly curable, with five-year survival rates exceeding 90 percent.
  • One in 58 men and women will be diagnosed with melanoma during their lifetime. Caucasians and men older than 50 years of age are at a higher risk of developing melanoma than the general population.
  • It is estimated that there will be about 121,840 new cases of melanoma in 2009 — 53,120 noninvasive ( in situ ) and 68,720 invasive (39,080 men and 29,640 women).
  • One American dies of melanoma almost every hour (every 61  minutes). In 2009, 8,650 deaths will be attributed to melanoma —  5,550 men and 3,100 women.
  • The World Health Organization estimates that as many as 65,161 people a year worldwide die from too much sun, mostly from  malignant skin cancer.
  • People with more than 50 moles, atypical moles, or a family history of melanoma are at an increased risk of developing melanoma.
  • About 75 percent of skin cancer deaths are from melanoma.
  • The five-year survival rate for people whose melanoma is detected and treated before it spreads to the lymph nodes is 99 percent.
  • Five-year survival rates for regional and distant stage melanomas are 65 percent and 15 percent, respectively.
  • In 2004, the total direct cost associated with the treatment for non-melanoma skin cancer was $1.5 billion.
  • The American Cancer Society recommends a skin cancer-related checkup and counseling about sun exposure as part of any periodic health examination for men and women beginning at age 20.
  • Individuals with a history of melanoma should have a full body exam at least annually and perform regular self-exams for new and changing moles.

 

back to the top